A complete application in a minute
Tailored resume and cover letter, ready to send.
Piramal Pharma Solutions is seeking a QC Analyst II - Stability to perform analytical testing of stability samples and support the Stability Program. You will execute studies, review data, and ensure compliance with cGMP and ICH guidelines while collaborating with QA, Regulatory Affairs, and Manufacturing.
The role requires a Bachelor’s degree in a related science and 2–4 years of QC laboratory experience, with hands-on use of HPLC/UPLC/GC and Empower or LIMS systems in a regulated environment.
Be the First to Apply Division Piramal Pharma Solutions Piramal Pharma Solutions is a contract development and manufacturing organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our clients through a globally integrated network of facilities in North America, Europe and Asia. This enables us to offer a comprehensive range of services including Drug Discovery Solutions, Process & Pharmaceutical Development services, Clinical Trial Supplies, Commercial supply of APIs and Finished dosage forms. We also offer specialized services like development and manufacture of Highly Potent APIs and Antibody Drug Conjugation. Our capability as an integrated service provider & experience with various technologies enables us to serve Innovator and Generic companies worldwide. For more details, please visit : www.piramalpharmasolutions.com
The QC Analyst II - Stability is responsible for performing analytical testing of stability samples in support of the site's Stability Program. This role executes stability studies, performs chromatographic and compendial testing, reviews analytical data, monitors study timelines, and ensures compliance with cGMP requirements, ICH guidelines, approved protocols, and regulatory commitments. The analyst collaborates closely with Quality Control, Quality Assurance, Regulatory Affairs, and Manufacturing to maintain an effective and compliant stability program.
Frequent standing, walking, bending, reaching, and lifting may be required.
Ability to lift and carry laboratory materials, reagents, and sample containers up to 25 pounds.
Extended periods of sitting, computer use, data review, and documentation activities are required.
Frequent use of laboratory instruments, analytical equipment, and computerized systems.
Ability to perform repetitive tasks requiring attention to detail and manual dexterity.
Work is performed primarily in a Quality Control laboratory supporting pharmaceutical manufacturing operations.
Regular exposure to laboratory equipment including HPLC, UPLC, GC, dissolution systems, balances, and other analytical instrumentation.
Responsibilities may include working within stability sample storage areas and environmental chambers.
Potential limited exposure to laboratory chemicals, solvents, and pharmaceutical materials.
Personal protective equipment (PPE), including safety glasses, laboratory coats, gloves, and appropriate footwear, is required as designated by site procedures.
Compliance with cGMP requirements, data integrity principles, laboratory safety procedures, and applicable regulatory requirements is expected at all times.
Occasional support may be required during investigations, audits, stability study deadlines, or business-critical testing activities.
Piramal Pharma Limited, offers a portfolio of differentiated products and services through its 17 global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organization; Piramal Critical Care (PCC), a Complex Hospital Generics business; and the India Consumer Healthcare business, selling over-the- counter products. In addition, one of PPL’s associate companies, AbbVie Therapeutics India Private Limited is a JV with AbbVie Inc. and has emerged as one of the market leaders in the ophthalmology therapy area. Further, PPL has a minority investment in Yapan Bio Private Limited. In October 2020, PPL received a 20% strategic growth investment from the Carlyle Group.
PPL provides equal employment opportunities to all employees and applicants for employment. It prohibits discrimination and harassment based on race, color, age, sex, religion, national origin or ethnicity, disability status, genetics, protected veteran status, sexual orientation, gender identity, or expression, or any other characteristic protected by applicable law. Our employment decisions are based on merit considering qualifications, skills, performance, and achievements. Equal employment opportunity applies to all terms and conditions of employment, including recruitment, selection, training, social programs, placement, promotion, demotion, compensation and benefits, transfers, terminations, and working conditions.